DOI: http://dx.doi.org/10.18203/2349-3259.ijct20173088

A randomized, double-blind, placebo-controlled, proof of concept study to assess the safety and efficacy of Carica papaya and Tinospora cordifolia leaf extract (Thrombobliss) in subjects undergoing chemotherapy treatment and subjects with systemic microbial infection and subsequent reduction in platelet count

Ramesh Babu, Suresh Kubavat, Poulose K. P., Srinivasa kumar K. P., Sonika Handae, Satyanarayana ., Vyas Dhamodaran, Balaji Elangovan

Abstract


Background: Thrombocytopenia is defined as persistent decrease in the number of blood platelets. Thrombocytopenia usually serves as symptom for identifying hematologic malignancies, infectious diseases, auto-immune disorders and as common side effect of about 200 different disease types. There was neither a specific treatment available for thrombocytopenia, nor to increase the platelet count leading to mortality. Current methods are less effective and have their limitations. This study was conducted to prove that Carica papaya and Tinospora cordifolia leaf extract can increase the platelet count in study subjects with dengue, other microbial infections.

Methods: Totally 250 patients were randomized, subjects within inclusion criteria and exclusion criteria were randomly assigned, in a 1:1 ratio, to receive orally thrombobliss in a dose of 5 ml syrup twice daily or placebo for five consecutive days. Platelet count was monitored every day.

Results: The result showed that there is increase in the platelet count from day 2 in median platelet data and more evident after 72 hours seen in both mean and median platelet count. Even in the cancer patients undergoing chemotherapy, there has been significant increase in platelet count. The statistical analysis of the data showed that there is a significant increase in platelet count and is statistical significant p<0.05.  

Conclusions: This study showed that novel combination of Carica papaya and Tinospora cordifolia leaf extract effectively increases platelet count and can be used to treat thrombocytopenia. It is also evident that this combination is safe and effective in treating thrombocytopenia patients due to dengue and other microbial infection.


Keywords


Thrombocytopenia, Carica papaya, Tinospora cordifolia, Platelet count

Full Text:

PDF

References


Buckley MF, James JW, Brown DE. A novel approach to the assessment of variations in the human platelet count. Thromb Haemost. 2000;83(3):480-4.

Aster RH. Pooling of platelets in the spleen: role in the pathogenesis of “hypersplenic” thrombo-cytopenia. J Clin Invest. 1966;45:645-57.

Jain S, Kamimoto L, Bramley AM. Pandemic Influenza A (H1N1) Virus Hospitalizations Investigation Team. Hospitalized patients with 2009 H1N1 influenza in the United States, April-June 2009. N Engl J Med. 2009;361(20):1935-44.

Chapman AS, Bakken JS, Folk SM. Tickborne Rickettsial Diseases Working Group; CDC. Diagnosis and management of tickborne rickettsial diseases: Rocky Mountain spotted fever, ehrlichiosis, and anaplasmosis - United States: a practical guide for physicians and other health-care and public health professionals. MMWR Recomm Rep. 2006;55(4):1-27.

WHO Global Malaria Program, World Malaria report 16. Available at: http://www.who.int/malaria/ world_malaria_report_2011/9789241564403_eng.pdf?ua= Accessed on 7 March 2017.

Konkle BA. Acquired disorders of platelet function. Hematology Am Soc Hematol Educ Program. 2011;2011:391-6.

Linkins L, Dans AL, Moores LK, Bona R, Davidson BL, Schulman S. Treatment and prevention of heparin-induced thrombocytopenia: Antithrombotic Therapy and Prevention of Thrombosis 9th ed.: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141:495-530.

Akca S, Haji-Michael P, de Mendonca A, Suter P, Levi M, Vincent JL. Time course of platelet counts in critically ill patients. Crit Care Med. 2002;30:753–6.

Marina Izak1, James B. Bussel. Management of thrombocytopenia. 1F1000 Prime Reports 2014;6:45.

Moulis G, Palmaro A, Montastruc JL, Godeau B, Lapeyre-Mestre M, Sailler L. Epidemiology of incident immune thrombocytopenia: a nationwide population-based study in France. Blood. 2014;124(22):3308-15.

Singh N, Dhakad A, Singh U, Tripathi AK, Pushplata S. Prevalence and Characterization of Thrombocytopenia in Pregnancy in Indian Women. Indian J Hematol Blood Transfus. 2012;28(2):77–81.

Neunert C, Lim W, Crowther M, Cohen A, Solberg L, Crowther MA. The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia. Blood 2011;117:4190-207.

Cines DB, Blanchette VS. Immune thrombocytopenic purpura. N Engl J Med. 2002;346(13):995-1008.

Provan D, Stasi R, Newland AC, Blanchette VS, Bolton-Maggs P, Bussel JB. International consensus report on the investigation and management of primary immune thrombocytopenia. Blood. 2010;115(2):168-86.

Mazzucconi MG, Fazi P, Bernasconi S, Rossi G de, Leone G, Gugliotta L. Therapy with high-dose dexamethasone (HD-DXM) in previously untreated patients affected by idiopathic thrombocytopenic purpura: a GIMEMA experience. Blood. 2007;109:1401-7.

Godeau B, Chevret S, Varet B, Lefrère F, Zini JM, Bassompierre F. Intravenous immunoglobulin or high-dose methylprednisolone, with or without oral prednisone, for adults with untreated severe autoimmune thrombocytopenic purpura: a randomised, multicentre trial. Lancet. 2002;359:23-9.

Al-Ahmari A, Ayas M, Al-Jefri A, Al-Mahr M, Rifai S, El-Solh H. Allogeneic stem cell transplantation for patients with congenital amegakaryocytic thrombocytopenia (CAT). Bone Marrow Transplant. 2004;33:829-31.

Sekhon SS, Roy V. Thrombocytopenia in adults: A practical approach to evaluation and management. South Med J. 2006;99(5):491-8.

Bussel JB, Kaufmann CP, Ware RE, Woloski BM. Do the acute platelet responses of patients with immune thrombocytopenic purpura (ITP) to IV anti-D and to IV gammaglobulin predict response to subsequent splenectomy? Am J Hematol. 2001;67:27-33.

Arumuganathan K, Earle ED. Nuclear DNA content of some important plant species. Plant Molecular Biol Reporter. 1991;9(3):208–18.

Verheij EWM, Coronel RE. Plant Resources of South-East Asia 2: Edible Fruits and Nuts. PROSEA. 1991;2:223–5.

Owoyele BV, Adebukola OM, Funmilayo AA, and Soladoye AO. Anti-inflammatory activities of ethanolic extract of Carica papaya leaves. Inflammopharmacol. 2008;16(4):168–73.

Gurung S, Skalko-Basnet N. Wound healing properties of Carica papaya latex: in vivo evaluation in mice burn model. J Ethnopharmacol. 2009;121(2):338–41.

Otsuki N, Dang NH, Kumagai E, Kondo A, Iwata S, Morimoto C. Aqueous extract of Carica papaya leaves exhibits anti-tumor activity and immunomodulatory effects. J Ethnopharmacol. 2010;127(3):760–7.

Halim SZ, Abdullah NR, Afzan Z, Abdul Rashid BA, Jantan I, Ismail Z. Acute toxicity of Carica papaya leaf extract in Sprague Dawley rats. J Med Plants Res. 2011;5(10):1867–72.

Upadhyay AK, Kumar K, Kumar A, Mishra HS. Tinospora cordifolia (Willd.) Hook. f. and Thoms. (Guduchi) – validation of the Ayurvedic pharmacology through experimental and clinical studies. Int J Ayurveda Res. 2010;1(2):112–21.

Parikh F. Infections and Thrombocytopenia. J Associat Physicians India. 2016;64:11-2.

Aravind G, Bhowmik D, Duraivel S, Harish G. Traditional and Medicinal Uses of Carica papaya. J Med Plants Studies. 2013;1(1):7- 15.

Ahmad N, Fazal H, Ayaz M, Abbasi BH, Mohammad I, Fazal L. Dengue fever treatment with Carica papaya leaves extracts. Asian Pac J Trop Biomed. 2011;1(4):330–3.

Tahir N, Zaheer Z, Kausar S, Chiragh S. Prevention of fall in platelet count by Carica papaya leaf juice in carboplatin induced thrombocytopaenia in mice. Biomedical. 2014;30(1):21-5.

Kuter DJ. Managing Thrombocytopenia Associated With Cancer Chemotherapy. Oncology (Williston Park). 2015;29(4):282-94.